Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Haemonetics (NYSE: HAE) announced its second quarter fiscal 2026 financial results for the period ended September 27, 2025 are available on the company's Investor Relations website.
The company will host a live conference call and webcast with investors and analysts at 8:00 a.m. ET on November 6, 2025. A replay will be available beginning at 11:00 a.m. ET on November 6, 2025 and will remain accessible for one year via the webcast link. Earnings materials posted include the Second Quarter Fiscal 2026 Earnings Release and a Supplemental Earnings Presentation.
Haemonetics (NYSE: HAE) ha annunciato i risultati finanziari del secondo trimestre fiscale 2026 per il periodo chiuso il 27 settembre 2025 disponibili sul sito di Investor Relations dell'azienda.
L'azienda ospiterà una conferenza telefonica in diretta e una trasmissione webcast con investitori e analisti alle 8:00 a.m. ET del 6 novembre 2025. Una replica sarà disponibile a partire dalle 11:00 a.m. ET del 6 novembre 2025 e resterà accessibile per un anno tramite il link della webcast. I materiali sugli utili pubblicati includono il Secondo trimestre fiscale 2026 - Earnings Release e una Presentazione integrativa sugli utili.
Haemonetics (NYSE: HAE) anunció sus resultados financieros del segundo trimestre fiscal 2026 para el período terminado el 27 de septiembre de 2025 y están disponibles en el sitio de Relaciones con Inversores de la empresa.
La compañía organizará una llamada de conferencia en vivo y una transmisión web con inversores y analistas a las 8:00 a.m. ET el 6 de noviembre de 2025. Una reproducción estará disponible a partir de las 11:00 a.m. ET el 6 de noviembre de 2025 y permanecerá accesible durante un año a través del enlace de la transmisión web. Los materiales de resultados publicados incluyen el Comunicado sobre resultados del segundo trimestre fiscal 2026 y una Presentación de resultados suplementaria.
하이메네틱스(Haemonetics) (NYSE: HAE)가 2026 회계연도 2분기의 재무 실적을 발표했으며, 기간은 2025년 9월 27일에 종료되었습니다. 회사의 투자자 관계 웹사이트에서 확인할 수 있습니다.
회사는 투자자 및 애널리스트와의 라이브 컨퍼런스 콜 및 웹캐스트를 2025년 11월 6일 오전 8:00 ET에 개최할 예정입니다. 재방송은 2025년 11월 6일 오전 11:00 ET부터 이용 가능하며, 웹캐스트 링크를 통해 1년 동안 접근할 수 있습니다. 발표 자료에는 2026 회계연도 2분기 실적 발표와 보충 실적 자료가 포함되어 게시됩니다.
Haemonetics (NYSE: HAE) a annoncé ses résultats financiers du deuxième trimestre fiscal 2026 pour la période se terminant le 27 septembre 2025, disponibles sur le site des Relations avec les investisseurs de l'entreprise.
L'entreprise tiendra une conférence téléphonique en direct et une webcast avec les investisseurs et les analystes à 8 h 00 (heure de l'Est) le 6 novembre 2025. Une reprise sera disponible à partir de 8 h 00 (HE) / 11 h 00 ET et restera accessible pendant un an via le lien de webcast. Les documents relatifs aux résultats publiés comprennent le Communiqué sur les résultats du deuxième trimestre fiscal 2026 et une Présentation des résultats complémentaires.
Haemonetics (NYSE: HAE) hat seine Ergebnisse des zweiten Quartals des Geschäftsjahres 2026 für den Zeitraum bis zum 27. September 2025 bekannt gegeben und sind auf der Website des Investor Relations verfügbar.
Das Unternehmen wird eine Live-Konferenzschaltung und einen Webcast mit Investoren und Analysten um 8:00 Uhr ET am 6. November 2025 durchführen. Eine Wiederholung steht ab 11:00 Uhr ET am 6. November 2025 zur Verfügung und bleibt für ein Jahr über den Webcast-Link zugänglich. Veröffentlicht wurden Unterlagen enthalten den Bericht zum zweiten Quartal des Geschäftsjahres 2026 und eine Zusätzliche Ergebnispräsentation.
هايمنيتكس (NYSE: HAE) أعلن عن نتائجه المالية للربع الثاني من السنة المالية 2026 للفترة المنتهية في 27 سبتمبر 2025 وهي متاحة على موقع العلاقات مع المستثمرين للشركة.
ستعقد الشركة مكالمة مؤتمر مباشرة وبثاً عبر الويب مع المستثمرين والمحللين في 8:00 صباحاً بتوقيت شرق الولايات المتحدة في 6 نوفمبر 2025. ستكون هناك إعادة للبث متاحة اعتباراً من 11:00 صباحاً بتوقيت شرق الولايات المتحدة في 6 نوفمبر 2025 وستظل متاحة لمدة عام عبر رابط البث. تشمل مواد الأرباح المنشورة إصدار أرباح الربع الثاني من السنة المالية 2026 وعرض تقديمي مكمل للأرباح.
- None.
- None.
Financial release and supplemental presentation accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 6, 2025.
Conference Call and Webcast Information:
- Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
- Live webcast: Access here or through the Investor Relations section of the Haemonetics website.
A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on November 6, 2025 and will remain accessible for one year via the webcast link above.
Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:
- Second Quarter Fiscal 2026 Earnings Release
- Second Quarter Fiscal 2026 Supplemental Earnings Presentation
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
|
Investor Contacts: |
|
|
Olga Guyette, Vice President-Investor Relations & Treasury |
David Trenk, Manager-Investor Relations |
|
(781) 356-9763 |
(203) 733-4987 |
|
|
|
|
Media Contact: |
|
|
Josh Gitelson, Sr. Director-Global Communications |
|
|
(781) 356-9776 |
|
|
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-second-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302606803.html
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics (HAE) discuss Q2 fiscal 2026 results?
Where can I find Haemonetics (HAE) Q2 fiscal 2026 earnings release and presentation?
How can investors join the Haemonetics (HAE) conference call on November 6, 2025?
Will there be a replay of the Haemonetics (HAE) Q2 fiscal 2026 webcast?
What time period does Haemonetics' Q2 fiscal 2026 cover for the November 6, 2025 results?
